JP4696543B2 - 新規蛋白質、その医薬用途、その蛋白質の遺伝子のプロモーターおよびその用途 - Google Patents

新規蛋白質、その医薬用途、その蛋白質の遺伝子のプロモーターおよびその用途 Download PDF

Info

Publication number
JP4696543B2
JP4696543B2 JP2004351903A JP2004351903A JP4696543B2 JP 4696543 B2 JP4696543 B2 JP 4696543B2 JP 2004351903 A JP2004351903 A JP 2004351903A JP 2004351903 A JP2004351903 A JP 2004351903A JP 4696543 B2 JP4696543 B2 JP 4696543B2
Authority
JP
Japan
Prior art keywords
protein
self
seq
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004351903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006158244A (ja
JP2006158244A5 (enExample
Inventor
紀子 中村
哲央 須藤
高利 山田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP2004351903A priority Critical patent/JP4696543B2/ja
Publication of JP2006158244A publication Critical patent/JP2006158244A/ja
Publication of JP2006158244A5 publication Critical patent/JP2006158244A5/ja
Application granted granted Critical
Publication of JP4696543B2 publication Critical patent/JP4696543B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2004351903A 2004-12-03 2004-12-03 新規蛋白質、その医薬用途、その蛋白質の遺伝子のプロモーターおよびその用途 Expired - Fee Related JP4696543B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004351903A JP4696543B2 (ja) 2004-12-03 2004-12-03 新規蛋白質、その医薬用途、その蛋白質の遺伝子のプロモーターおよびその用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004351903A JP4696543B2 (ja) 2004-12-03 2004-12-03 新規蛋白質、その医薬用途、その蛋白質の遺伝子のプロモーターおよびその用途

Publications (3)

Publication Number Publication Date
JP2006158244A JP2006158244A (ja) 2006-06-22
JP2006158244A5 JP2006158244A5 (enExample) 2008-01-24
JP4696543B2 true JP4696543B2 (ja) 2011-06-08

Family

ID=36660894

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004351903A Expired - Fee Related JP4696543B2 (ja) 2004-12-03 2004-12-03 新規蛋白質、その医薬用途、その蛋白質の遺伝子のプロモーターおよびその用途

Country Status (1)

Country Link
JP (1) JP4696543B2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0523373D0 (en) * 2005-11-16 2005-12-28 Ares Trading Sa Nidogen/snep-like molecule
US20130086704A1 (en) * 2010-06-21 2013-04-04 Tokyo Institute Of Technology Pharmaceutical composition utilizing pancreatic beta cell proliferation factor
JP5888852B2 (ja) * 2010-12-08 2016-03-22 学校法人近畿大学 免疫不全動物を用いた細胞の製法

Also Published As

Publication number Publication date
JP2006158244A (ja) 2006-06-22

Similar Documents

Publication Publication Date Title
JP3803681B2 (ja) 血管形成及び心臓血管新生の促進又は阻害
JP6033531B2 (ja) 血管形成に関連する障害を診断及び治療するための組成物と方法
US7115415B2 (en) PRO9821 nucleic acids
JPH07501212A (ja) ＴＧＦ−β型受容体ｃＤＮＡおよびその用途
JPH11509187A (ja) 内皮細胞増殖の調節
JPH10507646A (ja) マクロファージ由来ケモカインおよびケモカインアナログ
JP2018535964A (ja) 線維芽細胞増殖因子（ｆｇｆ）１アナログによるステロイド誘導性高血糖の処置
JP2004154140A (ja) 血管形成及び心血管新生の促進又は阻害
JP2003531811A5 (enExample)
KR100543857B1 (ko) 혈관신생 및 심혈관형성의 촉진 또는 억제
WO2014061749A1 (ja) ２型ｔｎｆ受容体の発現を抑制する合成ペプチド及びその利用
US7217539B2 (en) Cell death inducers for mast cells
JP2002526099A (ja) Ｎｌｋ１−相互作用タンパク質
JP4696543B2 (ja) 新規蛋白質、その医薬用途、その蛋白質の遺伝子のプロモーターおよびその用途
KR100885545B1 (ko) Ｒａｎｋ 저해 활성을 갖는 폴리펩티드, 그를 포함하는약학적 조성물, 그를 이용한 개체의 파골세포 분화를억제하는 방법 및 파골세포의 분화 및 활성화로 인하여야기되는 질병을 치료 또는 예방하는 방법, 그를 코딩하는핵산, 상기 핵산을 포함하는 벡터 및 숙주세포
KR20010043090A (ko) 신규인 폴리펩티드, 그 폴리펩티드를 코드화하는 ｃＤＮＡ및 그 용도
US7691577B2 (en) Protein having an EGF-like repeat sequence
CN101190944A (zh) 人类新细胞因子及其用途
JP2003189872A (ja) 新規なポリペプチドＥＳＤＮ、その製造方法、ＥＳＤＮをコードするｃＤＮＡ、そのｃＤＮＡからなるベクター、そのベクターで形質転換された宿主細胞、ＥＳＤＮの抗体、ＥＳＤＮまたは抗体を含有する薬学的組成物、ＥＳＤＮを用いたスクリーニング方法、および抗ＥＳＤＮ抗体を用いたＥＳＤＮの免疫化学測定法
KR20100091322A (ko) 골다공증의 예방 또는 치료 활성을 갖는 물질의 스크리닝 방법
US20100111913A1 (en) Method of enhancing migration of neural precursor cells
JP4283531B2 (ja) マスト細胞の細胞死誘発剤
JP2007308407A (ja) 平滑筋細胞分化増殖抑制剤
US8084434B2 (en) Runx2 isoforms in angiogenesis
JPWO2007058336A1 (ja) Ｒｅｃ１６８を介する肥満細胞の脱顆粒反応抑制物質またはプロスタグランジンＤ２産生抑制物質のスクリーニング方法及び同定方法、並びにそれら物質を含有してなる炎症性疾患の治療剤

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100727

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100909

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101019

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101206

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20101221

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110201

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110214

LAPS Cancellation because of no payment of annual fees